Shiva Seirafian

498 total citations
39 papers, 391 citations indexed

About

Shiva Seirafian is a scholar working on Nephrology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Shiva Seirafian has authored 39 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 9 papers in Epidemiology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Shiva Seirafian's work include Dialysis and Renal Disease Management (11 papers), Central Venous Catheters and Hemodialysis (5 papers) and Chronic Kidney Disease and Diabetes (3 papers). Shiva Seirafian is often cited by papers focused on Dialysis and Renal Disease Management (11 papers), Central Venous Catheters and Hemodialysis (5 papers) and Chronic Kidney Disease and Diabetes (3 papers). Shiva Seirafian collaborates with scholars based in Iran, United Kingdom and Nigeria. Shiva Seirafian's co-authors include Shahram Taheri, Shahrzad Shahidi, Ali Momeni, Soleiman Kheiri, Mojgan Mortazavi, Mohammad Garakyaraghi, Iraj Najafi, Mostafa Hosseini, Abdolamir Atapour and Shahnaz Atabak and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and BMJ Open.

In The Last Decade

Shiva Seirafian

38 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiva Seirafian Iran 10 184 100 82 76 73 39 391
Yu‐Ji Lee South Korea 13 142 0.8× 78 0.8× 61 0.7× 60 0.8× 27 0.4× 41 404
Chiu‐Ching Huang Taiwan 12 178 1.0× 89 0.9× 34 0.4× 58 0.8× 18 0.2× 32 453
Colin T. White Canada 14 261 1.4× 61 0.6× 95 1.2× 32 0.4× 18 0.2× 28 542
Francisco Coronel Spain 14 318 1.7× 116 1.2× 42 0.5× 74 1.0× 20 0.3× 60 548
Ali Kemal Kadiroğlu Türkiye 13 171 0.9× 95 0.9× 54 0.7× 49 0.6× 12 0.2× 49 480
Eyüp Külah Türkiye 12 141 0.8× 95 0.9× 92 1.1× 18 0.2× 30 0.4× 27 365
Tsutomu Sakurada Japan 12 339 1.8× 115 1.1× 76 0.9× 33 0.4× 16 0.2× 77 559
Anjali Mohapatra India 11 161 0.9× 37 0.4× 23 0.3× 166 2.2× 54 0.7× 41 552
Jeng‐Yi Huang Taiwan 14 199 1.1× 69 0.7× 58 0.7× 40 0.5× 10 0.1× 26 492
Dušan Paripović Serbia 12 223 1.2× 74 0.7× 81 1.0× 26 0.3× 17 0.2× 43 439

Countries citing papers authored by Shiva Seirafian

Since Specialization
Citations

This map shows the geographic impact of Shiva Seirafian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiva Seirafian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiva Seirafian more than expected).

Fields of papers citing papers by Shiva Seirafian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiva Seirafian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiva Seirafian. The network helps show where Shiva Seirafian may publish in the future.

Co-authorship network of co-authors of Shiva Seirafian

This figure shows the co-authorship network connecting the top 25 collaborators of Shiva Seirafian. A scholar is included among the top collaborators of Shiva Seirafian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiva Seirafian. Shiva Seirafian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moeinzadeh, Firouze‬h, Mohammad Hossein Rouhani, Shiva Seirafian, et al.. (2023). Metabolic health status and renal disorders: a cross-sectional study. Scientific Reports. 13(1). 3 indexed citations
2.
Mortazavi, Mojgan, et al.. (2017). The relationship of high-sensitivity C-reactive protein (Hs-CRP) serum level and peritonitis in patients on peritoneal dialysis. SHILAP Revista de lepidopterología. 35(419). 119–123. 1 indexed citations
3.
Mortazavi, Mojgan, et al.. (2017). Comparing the Effect of Dressing Versus No-dressing on Exit Site Infection and Peritonitis in Chronic Ambulatory Peritoneal Dialysis Patients. SHILAP Revista de lepidopterología. 6(1). 5–5. 7 indexed citations
4.
Hosseini, Sayed Mohsen, et al.. (2017). Predicting Tree-Year Clinical Outcomes Using the Baseline and Trajectories of Serum Albumin in Patients on Peritoneal Dialysis. Iranian Red Crescent Medical Journal. 19(10). 2 indexed citations
5.
Taheri, Diana, et al.. (2015). Acute oxalate nephropathy following kidney transplantation: Report of three cases. Journal of Research in Medical Sciences. 20(8). 818–818. 7 indexed citations
6.
Mortazavi, Mojgan, et al.. (2014). The effect of oral vitamin D on serum level of N-terminal pro-B-type natriuretic peptide. SHILAP Revista de lepidopterología. 3(1). 261–261. 5 indexed citations
7.
Shahidi, Shahrzad, et al.. (2012). Intestinal fungal and parasitic infections in kidney transplant recipients: A multi-center study. Saudi Journal of Kidney Diseases and Transplantation. 23(4). 677–677. 12 indexed citations
8.
Seirafian, Shiva, Ali Momeni, Shahram Taheri, Mojgan Mortazavi, & Zamzam Paknahad. (2012). Serum leptin level has a positive correlation with BMI and creatinine clearance in CAPD patients. Bratislavské lekárske listy/Bratislava medical journal. 113(8). 486–489. 2 indexed citations
9.
Mortazavi, Mojgan, et al.. (2011). The Effect of Oral L-carnitine on Serum Albumin and Inflammatory Markers Levels in Patients under Peritoneal Dialysis: A Randomized Controlled Trial. SHILAP Revista de lepidopterología. 5 indexed citations
10.
Momeni, Ali & Shiva Seirafian. (2011). Relationship Between Serum Leptin Level and Peritonitis in CAPD Patients. Nephro-Urology Monthly. 2011(4). 272–275. 1 indexed citations
11.
Taheri, Shahram, Farshid Kafilzadeh, Majid Yaran, et al.. (2011). Comparison of polyomavirus (BK virus and JC viruses) viruria in renal transplant recipients with and without kidney dysfunction.. PubMed. 16(7). 916–22. 13 indexed citations
12.
Taheri, Shahram, Farshid Kafilzadeh, Majid Yaran, et al.. (2011). Comparison of polyomavirus (BK virus and JC viruses) viruria in renal transplant recipients with and without kidney dysfunction. SHILAP Revista de lepidopterología. 7 indexed citations
13.
Najafi, Iraj, Shahrzad Ossareh, Mostafa Hosseini, et al.. (2011). Epidemiology of culture-negative peritonitis in Iranian patients on continuous ambulatory peritoneal dialysis.. PubMed. 5(5). 332–7. 9 indexed citations
14.
Shahidi, Shahrzad, et al.. (2010). Effect of Pioglitazone on proteinuria in non-diabetic renal patients: a self-control clinical trial. SHILAP Revista de lepidopterología. 28(112). 632–639. 1 indexed citations
15.
Momeni, Ali, Shahrzad Shahidi, Shiva Seirafian, Shahram Taheri, & Soleiman Kheiri. (2010). Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients.. PubMed. 4(2). 128–32. 110 indexed citations
16.
Najafi, Iraj, Saeed Safari, Mostafa Hosseini, et al.. (2010). Prophylactic fluid therapy in crushed victims of Bam earthquake. The American Journal of Emergency Medicine. 29(7). 738–742. 29 indexed citations
17.
18.
Seirafian, Shiva, et al.. (2007). The Relation between Serum Creatinine and Renal Resistance Index in Parenchymal Kidney Disease. Iranian Journal of Radiology. 4(2). 109–112. 1 indexed citations
19.
Shahidi, Shahrzad, et al.. (2006). Does Tunneling the Temporary Vascular Access Extend Its Lifetime. Journal of Research in Medical Sciences. 11(1). 41–47. 5 indexed citations
20.
Taheri, Shahram, et al.. (2005). Response Rate to Hepatitis B Vaccination in Patients with Chronic Renal Failure and End-Stage-Renal-Disease: Influence of Diabetes Mellitus. SHILAP Revista de lepidopterología. 10(6). 384–390. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026